This post is presented by our media partner Cannabis News Wire
View the original article here.
The government of Ukraine recently approved a list of medical conditions that qualify for medical marijuana following the enactment of the country’s marijuana legislation by President Volodymyr Zelensky. The Ministry of Health shared a list of roughly 20 medical conditions eligible for marijuana treatment, noting that more conditions could be included later if medically approved.
The current list covers a variety of health issues, including neuropathy, multiple sclerosis, shingles, cerebral palsy, chemotherapy-related complications, childhood epilepsy and Parkinson’s disease.
While Zelensky and other officials have said access to medical marijuana can help soldiers address mental and physical wounds incurred during the nation’s ongoing war with Russia, post-traumatic stress disorder (PTSD) is currently not a qualifying medical condition.
The Ministry of Health also clarified the guidelines for using marijuana-based medicines, emphasizing the need for strict state control. Patients are advised to stop treatment if they don’t see therapeutic effects within one to three months or if they experience serious side effects, including mental-health issues.
The country has begun importing cannabis products following the decision to move marijuana from list 1 to list 2 of Ukraine’s drug classification system. This shift allows cannabis to be prescribed for medical use.
The legislation was initially approved last year but faced opposition when the Batkivshchyna party attempted to block it by introducing a resolution to repeal the bill. That resolution was ultimately rejected in January this year, clearing the way for the law to take effect. Opponents of the measure also tried to stop it by submitting hundreds of amendments, described by critics as “spam,” to slow the process. Despite these efforts, 248 votes were cast in favor of the bill.
The responsibility for regulating marijuana cultivation and processing will fall to Ukraine’s Ministry of Agrarian Policy. The State Agency on Medicines and the National Police will oversee the distribution of cannabis for medical use and ensure compliance with the law.
Zelensky has been vocal in his support for medical cannabis. In an address to parliament last year, he urged lawmakers to adopt best practices from around the world to help alleviate the pain and suffering of Ukrainians, especially given the country’s ongoing war. He stressed the need to legalize marijuana-based medicines for persons in need while ensuring that production is properly regulated.
The current reform is opposed to that of Russia, Ukraine’s longstanding foe. Russia has always opposed marijuana reform on a national and international level and has expressed disapproval of nations such as Canada that have legalized the drug.
The medical marijuana program is taking shape in Ukraine, and it might be an industry that companies such as Aurora Cannabis Corp. (NASDAQ: ACB) (TSX: ACB) could keep an eye on since it could present an international market that they could venture into.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
This post was originally published by our media partner here.